Skip to main content
. 2017 Nov 8;8:1472. doi: 10.3389/fimmu.2017.01472

Figure 8.

Figure 8

Life expectancy for cancer patients allergic and desensitized to carboplatin and non-allergic to carboplatin [from Sloane et al. (33)]. Allergic and non-allergic ovarian cancer patients treated with carboplatin or carboplatin desensitization presented a similar life expectancy with a non significant advantage for the allergy desensitized patients.